The Horizon Europe MSCA-Doctoral Network NanoReMedi1 (“Functional Nano-Scaffolds for Regenerative Medicine”) is run by an International Consortium of Universities in cooperation with Companies and offers an innovative PhD level training in Nanomaterials for regenerative medicine to 13 Early Stage Researchers (ESR).
The scientific approach proposed by NanoReMedi Consortium is strongly multidisciplinary and involve a number of different state-of-the-art technologies/methodologies. Applicants are requested to choose among 13 different multidisciplinary projects strongly related to each other:
- Computational chemistry
- Chemical synthesis/peptide synthesis
- Peptide-based nanomaterials (Soft materials/Hydrogels/Electrospinning)
- Nanomaterials spectroscopic characterization
- Production of vein graph/3D-tissue fabrication/Biofilm prevention/Electrostimulated release of antimicrobial peptides
Doctorate Courses/Schools
Each ESR will attend the following training activities:
- Advanced courses and acquisition of soft/transferable skills provided by the home University’s doctorate courses/schools
- Nanomaterials preparation and characterization
- Network-wide multidisciplinary training activities at Network Meetings/Summer Schools
- 9 months secondment at one of the beneficiaries jointly awarding the doctoral degree
- 3 months secondment at one of the partners to acquire complementary skills
Your qualification
- Master’s degree in the fields of computational chemistry, organic chemistry, materials chemistry, materials engineering, chemical engineering, pharmaceutical chemistry, pharmacy, biotechnology, biomedical engineering.
- Very good performance in your studies and great enthusiasm for science
- Social competence, good English communication skills (B2 or higher), open-minded and flexibility.
How to apply Instructions on submission are provided on www.nanoremedi.eu (see open call)
Contact information nanoremedi@nanoremedi.eu
This project has received funding from the European Union’s Horizon Europe Marie Skłodowska-Curie-2021-DN-01 grant agreement n°101072645